Qinsheng Sun

Guangdong Key Laboratory Of Chinese Medicine Ingredients And Gut Microbiomics
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction to "Au@Fe3O4 Nanoparticle-Based Colorimetric Aptasensor for Noninvasive Screening of Colorectal Cancer via Detection of Parvimonas micra".

Correction to "Au@Fe3O4 Nanoparticle-Based Colorimetric Aptasensor for Noninvasive Screening of Colorectal Cancer via Detection of Parvimonas micra".

Journal: ACS sensors

Published: May 12, 2025

Huang-Lian-Jie-Du decoction enhances Capecitabine-Oxaliplatin efficacy via Akkermansia muciniphila and CD8+ T cells in colorectal cancer.

Huang-Lian-Jie-Du decoction enhances Capecitabine-Oxaliplatin efficacy via Akkermansia muciniphila and CD8+ T cells in colorectal cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 29, 2025

γ-Linolenic acid derived from Lactobacillus plantarum MM89 induces ferroptosis in colorectal cancer.

γ-Linolenic acid derived from Lactobacillus plantarum MM89 induces ferroptosis in colorectal cancer.

Journal: Food & function

Published: February 10, 2025

Au@Fe3O4 Nanoparticle-Based Colorimetric Aptasensor for Noninvasive Screening of Colorectal Cancer via Detection of Parvimonas micra.

Au@Fe3O4 Nanoparticle-Based Colorimetric Aptasensor for Noninvasive Screening of Colorectal Cancer via Detection of Parvimonas micra.

Journal: ACS sensors

Published: February 05, 2025

Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer.

Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer.

Journal: Scientific reports

Published: November 25, 2024

Solobacterium moorei promotes tumor progression via the Integrin α2/β1-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer.

Solobacterium moorei promotes tumor progression via the Integrin α2/β1-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer.

Journal: International journal of biological sciences

Published: August 23, 2024

Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy.

Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy.

Journal: Bioorganic & medicinal chemistry letters

Published: November 28, 2023

Antitumor Activity of s-Triazine Derivatives: A Systematic Review.

Antitumor Activity of s-Triazine Derivatives: A Systematic Review.

Journal: Molecules (Basel, Switzerland)

Published: April 27, 2023

Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.

Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.

Journal: Bioorganic & medicinal chemistry

Published: August 17, 2021

TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and a potential therapeutic target for colorectal cancer.

TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and a potential therapeutic target for colorectal cancer.

Journal: Cell death discovery

Published: July 16, 2021

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.

Journal: Cancer medicine

Published: January 04, 2021

Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines.

Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines.

Journal: European journal of medicinal chemistry

Published: October 29, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026